Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma - Authors' reply. (2017)

First Author: Smyth EC
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(17)30261-9

PubMed Identifier: 28495289

Publication URI: http://europepmc.org/abstract/MED/28495289

Type: Journal Article/Review

Volume: 18

Parent Publication: The Lancet. Oncology

Issue: 5

ISSN: 1470-2045